Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe most common side effects of the Wegovy pill are gastrointestinal — nausea, diarrhoea and constipation — reported in clinical trials by around three-quarters of participants taking oral semaglutide, compared with roughly four in ten on placebo. Most settle within days to a couple of weeks as your body adjusts to the medicine. The Wegovy tablet (semaglutide 25mg maintenance dose) is a prescription-only medicine; a prescriber assesses your full health picture before recommending it, and how side effects affect you personally is part of that conversation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The scenario is familiar to many people starting oral semaglutide: first thing in the morning, tablet swallowed with a sip of water, kettle ignored for now. Twenty minutes later, a wave of nausea arrives uninvited. This is not a sign something has gone wrong. Semaglutide works partly by slowing how quickly food leaves the stomach, a mechanism that is effective for appetite and weight management but that the gut notices, especially at the start and after each dose increase.
In the phase 3 OASIS 4 trial, 74% of people taking oral semaglutide reported gastrointestinal side effects, against 42% on placebo. The most frequent were nausea, diarrhoea, vomiting, constipation and indigestion. The NHS medicines page for semaglutide lists these in plain language alongside practical advice on managing them. For most people, the nausea is mild to moderate and peaks shortly after starting or moving up a dose, then quietens down over the following days to two weeks.
Staying hydrated matters. If vomiting or diarrhoea is severe and persistent, dehydration becomes a real concern, and that can affect kidney function. Our detailed guide to Wegovy pill form side effects covers hydration and practical steps for making the first weeks more comfortable. The key point: the pattern of early-onset, easing GI effects is well-documented and expected, it is not a reason to stop the tablet without speaking to your prescriber first.
Most of what people experience on the Wegovy tablet is uncomfortable rather than dangerous. A handful of reactions, though, should not be left to see if they resolve on their own.
The most important: acute pancreatitis. On 29 January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines specifically flagging pancreatitis as an infrequent but serious risk. The symptom to act on is severe, persistent stomach pain (often described as going through to the back) with or without vomiting. If you experience this, get medical help the same day. Do not put it down to the usual GI effects of the tablet. You can read the full MHRA safety communication via the Yellow Card reporting site, which is also where patients can report any suspected side effect they want the regulator to be aware of.
Other reactions to discuss promptly with a clinician include: signs of a serious allergic reaction (swelling of the face, throat or tongue, difficulty breathing), gallbladder symptoms (sharp pain under the right ribs, fever, yellowing of the skin), or significant low mood or thoughts of self-harm. These are uncommon, but the Patient Information Leaflet for the Wegovy tablet (available via the electronic medicines compendium (eMC)) lists every known reaction with its estimated frequency. Reading it before you start is time well spent.
People who want to understand how the injectable and tablet forms compare on tolerability can find that context on our semaglutide tablets overview page.
Some side effects are partly down to how the tablet is taken, not just the medicine itself. Oral semaglutide has strict requirements: empty stomach, plain water only (up to about 120ml), then a full 30-minute wait before coffee, breakfast or any other oral medicine. Skip the wait and absorption falls; eat too soon and nausea tends to be worse. It is a habit that takes some building, especially on mornings that do not have a natural routine around them.
The dosing schedule escalates slowly for a reason, 1.5mg, then 4mg, then 9mg, then 25mg at maintenance, with at least a month at each level. Each step up is the most likely moment for GI symptoms to return briefly, and our page on oral semaglutide side effects explains what to expect at each stage of the escalation. Knowing that this is the pattern, rather than evidence the medicine is not suiting you, makes the escalation easier to navigate.
Alcohol can worsen nausea on any GLP-1 medicine and is worth moderating, particularly in the first months. Fatty or very rich food tends to amplify upper GI discomfort. Our semaglutide tablets cost and treatment page explains what is included in the consultation, including the clinical support available when dose increases happen. For a broader look at how semaglutide's tablet and injectable forms sit within the wider treatment landscape, our weight-loss treatments overview offers useful context.
The Yellow Card scheme at yellowcard.mhra.gov.uk lets patients report suspected side effects directly to the MHRA, and reports from real-world use genuinely inform ongoing safety monitoring for a medicine as new as the Wegovy tablet, approved in the UK in June 2026. You do not need to be certain the medicine caused the problem; suspicion is enough to file a report.
At nume, aftercare runs seven days a week. If a side effect is worrying you between orders, that is exactly what the support line is for, you do not need to wait until your next review. Our prescribers, led by our clinical team, discuss tolerability as a central part of every consultation, not an afterthought. If you have questions before starting, you can read through our full breakdown of semaglutide pills side effects and our separate guide covering semaglutide tablets side effects, both of which address the practical points patients ask most. And if you are ready to have that conversation properly, starting a free consultation is where it begins, our prescribers talk through side effects and suitability together, so you know what to expect before your first tablet.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.